| __timestamp | Amgen Inc. | Bausch Health Companies Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4422000000 | 2254600000 |
| Thursday, January 1, 2015 | 4227000000 | 2645000000 |
| Friday, January 1, 2016 | 4162000000 | 2611000000 |
| Sunday, January 1, 2017 | 4069000000 | 2548000000 |
| Monday, January 1, 2018 | 4101000000 | 2351000000 |
| Tuesday, January 1, 2019 | 4356000000 | 2350000000 |
| Wednesday, January 1, 2020 | 6159000000 | 2249000000 |
| Friday, January 1, 2021 | 6454000000 | 2394000000 |
| Saturday, January 1, 2022 | 6406000000 | 2364000000 |
| Sunday, January 1, 2023 | 8415000000 | 2559000000 |
| Monday, January 1, 2024 | 12858000000 |
Unveiling the hidden dimensions of data
In the competitive landscape of the pharmaceutical industry, cost efficiency is a critical factor for success. This analysis delves into the cost of revenue trends for Amgen Inc. and Bausch Health Companies Inc. over the past decade, from 2014 to 2023. Amgen Inc. has demonstrated a significant increase in its cost of revenue, peaking at approximately 8.4 billion in 2023, a 90% rise from 2014. In contrast, Bausch Health Companies Inc. maintained a more stable cost structure, with a modest 13% increase over the same period, reaching around 2.6 billion in 2023. This stark contrast highlights Amgen's aggressive growth strategy, while Bausch Health focuses on maintaining steady operations. Understanding these trends provides valuable insights into each company's operational strategies and market positioning, offering a glimpse into their future trajectories.
Cost Insights: Breaking Down Eli Lilly and Company and Bausch Health Companies Inc.'s Expenses
AbbVie Inc. vs Amgen Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: Novartis AG and Bausch Health Companies Inc.
Cost of Revenue Comparison: Amgen Inc. vs Insmed Incorporated
Cost Insights: Breaking Down Amgen Inc. and Incyte Corporation's Expenses
Cost Insights: Breaking Down Vertex Pharmaceuticals Incorporated and Bausch Health Companies Inc.'s Expenses
Cost of Revenue: Key Insights for United Therapeutics Corporation and Bausch Health Companies Inc.
Cost of Revenue Comparison: Neurocrine Biosciences, Inc. vs Bausch Health Companies Inc.
Cost Insights: Breaking Down Intra-Cellular Therapies, Inc. and Bausch Health Companies Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Bausch Health Companies Inc.
Cost of Revenue Comparison: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
CRISPR Therapeutics AG vs Bausch Health Companies Inc.: Efficiency in Cost of Revenue Explored